Azacitidine



Indications and Reactions:

Role Indications Reactions
Primary
Drug Use For Unknown Indication 16.8%
Acute Myeloid Leukaemia 15.3%
Myelodysplastic Syndrome 14.7%
Prophylaxis 8.2%
Hypertension 6.6%
Nausea 5.6%
Constipation 5.1%
Antifungal Prophylaxis 4.4%
Thrombocytopenia 2.8%
Antiviral Prophylaxis 2.6%
Insomnia 2.3%
Mycosis Fungoides 2.1%
Benign Prostatic Hyperplasia 1.8%
Neutropenia 1.8%
Pneumonia 1.8%
Neutropenic Sepsis 1.6%
Premedication 1.6%
Product Used For Unknown Indication 1.6%
Antiemetic Supportive Care 1.5%
Coagulopathy 1.5%
Febrile Neutropenia 19.7%
Pneumonia 19.0%
Death 6.8%
Sepsis 5.4%
Thrombocytopenia 5.4%
Neutropenia 4.8%
Pyrexia 4.1%
White Blood Cell Count Decreased 4.1%
Hypotension 3.4%
Renal Failure Acute 3.4%
Dyspnoea 2.7%
Infection 2.7%
Pain 2.7%
Pancytopenia 2.7%
Pleural Effusion 2.7%
Abdominal Pain 2.0%
Acute Myeloid Leukaemia 2.0%
Ascites 2.0%
Cellulitis 2.0%
Cerebral Haemorrhage 2.0%
Secondary
Myelodysplastic Syndrome 14.1%
Acute Myeloid Leukaemia 11.2%
Breast Cancer 10.6%
Drug Use For Unknown Indication 10.3%
Hodgkin's Disease 10.2%
Lung Neoplasm Malignant 10.2%
Non-hodgkin's Lymphoma 10.1%
Product Used For Unknown Indication 4.7%
Prophylaxis 4.5%
Hypertension 2.6%
Constipation 1.6%
Nausea 1.6%
Pain 1.5%
Antifungal Prophylaxis 1.3%
Chronic Lymphocytic Leukaemia 1.1%
Thrombocytopenia 1.1%
Chronic Myeloid Leukaemia 0.9%
Chronic Myelomonocytic Leukaemia 0.8%
Lymphoma 0.8%
Neutropenia 0.8%
Febrile Neutropenia 14.1%
Pneumonia 14.1%
White Blood Cell Count Decreased 6.8%
Sepsis 5.2%
Pulmonary Fibrosis 4.7%
Acute Myeloid Leukaemia 4.2%
Diarrhoea 4.2%
First Trimester Pregnancy 4.2%
Neutropenia 4.2%
Rash 4.2%
Septic Shock 4.2%
Hypotension 3.7%
Lung Infection 3.7%
Platelet Count Decreased 3.7%
Respiratory Failure 3.7%
Neutrophil Count Decreased 3.1%
Pneumonitis 3.1%
Pyrexia 3.1%
Thrombocytopenia 3.1%
Anaemia 2.6%
Concomitant
Myelodysplastic Syndrome 19.3%
Product Used For Unknown Indication 14.5%
Acute Myeloid Leukaemia 13.4%
Prophylaxis 10.2%
Pain 5.6%
Iron Overload 4.8%
Infection Prophylaxis 4.3%
Biopsy Bone Marrow 3.2%
Premedication 3.2%
Bone Marrow Conditioning Regimen 2.7%
Prophylaxis Against Graft Versus Host Disease 2.4%
Dental Disorder Prophylaxis 2.1%
Hyperuricaemia 2.1%
Intravenous Catheter Management 2.1%
Prophylaxis Of Nausea And Vomiting 1.9%
Antacid Therapy 1.6%
Cardiovascular Disorder 1.6%
Clostridial Infection 1.6%
Diarrhoea 1.6%
Dyspepsia 1.6%
Nausea 14.8%
Acute Myeloid Leukaemia 9.8%
Therapeutic Response Decreased 6.6%
Venous Thrombosis 6.6%
White Blood Cell Count Decreased 6.6%
Drug Ineffective 4.9%
Myelofibrosis 4.9%
Pyrexia 4.9%
Renal Failure 4.9%
Thrombocytopenia 4.9%
Febrile Neutropenia 3.3%
Generalised Oedema 3.3%
Lung Disorder 3.3%
No Therapeutic Response 3.3%
Platelet Count Decreased 3.3%
Pneumonia 3.3%
Pseudomonal Sepsis 3.3%
Staphylococcal Infection 3.3%
Weight Decreased 3.3%
Abdominal Discomfort 1.6%